Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Am J Surg. 2024 Jul;233:17-23. doi: 10.1016/j.amjsurg.2023.12.013. Epub 2023 Dec 15.
While risk-stratified post-hepatectomy pathways (RSPHPs) reduce length-of-stay, can they stratify hepatectomy patients by risk of early postoperative events.
90-day outcomes from consecutive hepatectomies were analyzed (1/1/2017-12/31/2021). Pre/post-pathway analysis was performed for pathways: minimally invasive surgery ("MIS"); non-anatomic resection/left hepatectomy ("low-intermediate risk"); right/extended hepatectomy ("high-risk"); "Combination" operations. Time-to-event (TTE) analyses for readmission and interventional radiology procedures (IRPs) was performed.
1354 patients were included: MIS/n= 119 (9 %); low-intermediate risk/n= 443 (33 %); high-risk/n= 328 (24 %); Combination/n= 464 (34 %). There was no difference in readmission (pre: 13 % vs. post:11.5 %, p = 0.398). There were fewer readmissions in post-pathway patients amongst MIS, low-intermediate risk, and Combination patients (all p > 0.1). 114 (8.4 %) patients required IRPs. Time-to-readmission and time-to-IR-procedure plots demonstrated lower plateaus and flatter slopes for MIS/low-intermediate-risk pathways post-pathway implementation (p < 0.001).
RSPHPs can reliably stratify patients by risks of readmission or need for an IR procedure by predicting the most frequent period for these events.
虽然风险分层的肝切除术后途径(RSPHPs)可以减少住院时间,但它们能否根据术后早期事件的风险对肝切除术患者进行分层。
分析了连续肝切除术的 90 天结果(2017 年 1 月 1 日至 2021 年 12 月 31 日)。对以下途径进行了术前/术后途径分析:微创外科(“MIS”);非解剖性切除/左肝切除术(“低-中危”);右/扩大肝切除术(“高危”);“联合”手术。对再入院和介入放射学程序(IRP)进行了时间到事件(TTE)分析。
共纳入 1354 例患者:MIS/n=119(9%);低-中危/n=443(33%);高危/n=328(24%);联合/n=464(34%)。再入院率无差异(术前:13%vs.术后:11.5%,p=0.398)。MIS、低-中危和联合患者术后再入院率较低(均 p>0.1)。114(8.4%)例患者需要 IRP。再入院时间和 IR 程序时间图显示,术后实施 RSPHPs 后,MIS/低-中危途径的再入院率和 IR 程序需求的平台较低且斜率较平坦(p<0.001)。
RSPHPs 可以通过预测这些事件最常见的时期,可靠地对再入院或需要 IR 程序的风险进行分层。